Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 31, 2023 - Issue 3
Submit an article Journal homepage
154
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Clinical Outcomes in Vitrectomized versus Non-vitrectomized Eyes in Patients with Primary Vitreoretinal Lymphoma

Paulina Libermana Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA;b Departamento de Oftalmología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, ChileView further author information
, MD,
Jasmine H. Francisc Ocular Oncology Service, Memorial Sloan Kettering, New York, New York, USAORCID Iconhttps://orcid.org/0000-0002-7637-3108View further author information
, MDORCID Icon,
Karnika Mehrotraa Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USAView further author information
,
Jing Tiand Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USAView further author information
, MS,
Mark P. McGarreye Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USAView further author information
, BS,
Ethan K. Sobolc Ocular Oncology Service, Memorial Sloan Kettering, New York, New York, USAView further author information
, MD,
Jennifer E. Thornea Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USAView further author information
, MD, PhD,
Mary E. Aronowe Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USAView further author information
, MD &
Meghan K. Berkenstocka Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USACorrespondence[email protected]
View further author information
, MD show all
Pages 496-500 | Received 31 Aug 2021, Accepted 18 Jan 2022, Published online: 24 Feb 2022

References

  • Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report. Ann Oncol. 2007;18:1851–1855. doi:10.1093/annonc/mdm340.
  • Pulido JS, Johnston PB, Nowakowski GS, et al. The diagnosis and treatment of primary vitreoretinal lymphoma: a review. Int J Retina Vitreous. 2018;7(4):18. doi:10.1186/s40942-018-0120-4.
  • Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma. Surv Ophthalmol. 2014;59:503–516. doi:10.1016/j.survophthal.2013.12.001.
  • Tang L-J, Gu C-L, Zhang P. Intraocular lymphoma. Int J Ophthalmol. 2017;10:1301–1307. doi:10.18240/ijo.2017.08.19.
  • Coupland SE, Chan CC, Smith J. Pathophysiology of retinal lymphoma. Ocul Immunol Inflamm. 2009;17(4):227–237. doi:10.1080/09273940903168696.
  • Venkatesh P, Gogia V, Khanduja S, et al. Therapeutic vitrectomy for vitreal recurrence of intraocular lymphoma resistant to intravitreal methotrexate post systemic chemotherapy. J Can Res Ther. 2015;11:668. doi:10.4103/0973-1482.140824.
  • Iaccheri B, Fiore T, Cerquaglia A, et al. Transient therapeutic effect of vitrectomy in primary intraocular lymphoma. Int Ophthalmol. 2017;37:1333–1335. doi:10.1007/s10792-016-0405-2.
  • Bever GJ, Kim DJ, Afshar AR, et al. Therapeutic vitrectomy as an adjunct treatment to systemic chemotherapy for intraocular lymphoma. Retin Cases Brief Rep. 2020;14(2):116–119. doi:10.1097/ICB.0000000000000668.
  • Bach M, Schulze-Bonsel K, and Feltgen N, et al. Author response: numerical imputation for low vision states. Invest. Ophthalmol. Vis. Sci. 2007;eLetter:2.
  • Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467–471. doi:10.1016/S0161-6420(85)34001-0.
  • Riemens A, Bromberg J, Touitou V, et al. Treatment strategies in primary vitreoretinal lymphoma: a 17-Center European collaborative study. JAMA Ophthalmol. 2015;133:191–197. doi:10.1001/jamaophthalmol.2014.4755.
  • Farrall AL, Smith JR. Eye involvement in primary central nervous system lymphoma. Surv Ophthalmol. 2020;65(5):548–561. doi:10.1016/j.survophthal.2020.02.001.
  • Hormigo A, Abrey L, Heinemann M-H, DeAngelis LM. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br J Haematol. 2004;126:202–208. doi:10.1111/j.1365-2141.2004.05028.x.
  • Khan K, Jayaswal R, Madhusudhan S, Gibran SK. Macular OCT changes after vitrectomy. Ophthalmology. 2007;114:1955–1955.e1. doi:10.1016/j.ophtha.2007.04.033.
  • Kvopka M, Lake SR, Smith JR. Intraocular chemotherapy for vitreoretinal lymphoma: a review. Clin Exp Ophthalmol. 2020;48(2):240–248. doi:10.1111/ceo.13668.
  • Chan -C-C, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. Cancer Control. 2004;11:285–295. doi:10.1177/107327480401100502.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.